Joshua Fegan Archives | Page 2 of 3 | Cannabiz

Althea granted self-imposed ASX suspension amid failure to lodge notices to the market

by Steve Jones December 5, 2024December 11, 2024

Althea has been voluntarily suspended from the Australian Securities Exchange (ASX) after failing to release mandatory […]

Althea prepares for key vote as major shareholder continues to buy stock

by Steve Jones November 26, 2024November 26, 2024

Althea reports cash flow positive quarter but shaves top end of revenue guidance

by Steve Jones October 31, 2024February 25, 2025

Althea offloads clinic operation to Montu Group UK

by Steve Jones October 17, 2024October 17, 2024

Cannabis executive salaries: who earned what in FY24

by Steve Jones October 16, 2024October 15, 2025

Pathway to profitability ‘hugely tough’, but Althea boss keeps the faith

by Steve Jones May 28, 2024May 29, 2024

Company news: Cann Compounding; Ecofibre; Ora Pharm; Althea; Melodiol Global Health; Wellnex Life; Emyria

by Martin Lane and Steve Jones April 24, 2024November 25, 2024

Althea announces job cuts worth A$1.5m with more savings to come

by Martin Lane March 28, 2024March 28, 2024

Company news: Althea; Melodiol Global Health

by Steve Jones October 26, 2023April 30, 2024

Althea bosses agree to pay cut as group records first cash flow positive quarter

by Martin Lane October 11, 2023October 12, 2023